Schrodinger, Inc. (NASDAQ:SDGR) Given Consensus Rating of "Hold" by Analysts

Key Points

• Schrodinger, Inc. received a consensus rating of "Hold" from analysts, with one sell rating, three holds, and four buys; the average 12-month price target is $26.57.
• Institutional investors own 79.05% of Schrodinger's stock, with recent significant increases in holdings from firms like Geneos Wealth Management and Nikko Asset Management.
• In its latest quarterly report, Schrodinger reported an EPS of -$0.59, exceeding expectations, with year-over-year revenue growth of 15.7% to $54.76 million.

Shares of Schrodinger, Inc. (NASDAQ:SDGR - Get Free Report) have received a consensus rating of "Hold" from the eight brokerages that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $26.5714.

A number of equities research analysts have issued reports on SDGR shares. The Goldman Sachs Group started coverage on shares of Schrodinger in a report on Monday. They issued a "neutral" rating and a $19.00 price target on the stock. KeyCorp cut their price target on shares of Schrodinger from $32.00 to $30.00 and set an "overweight" rating on the stock in a report on Monday, July 14th. Weiss Ratings reissued a "sell (d-)" rating on shares of Schrodinger in a report on Saturday, September 27th. Citigroup lowered shares of Schrodinger from a "buy" rating to a "neutral" rating and cut their price target for the stock from $35.00 to $20.00 in a report on Friday, August 15th. Finally, Barclays started coverage on shares of Schrodinger in a report on Thursday, August 14th. They issued an "overweight" rating and a $25.00 price target on the stock.

Institutional Investors Weigh In On Schrodinger

A number of large investors have recently modified their holdings of the stock. State of Wyoming bought a new stake in shares of Schrodinger during the 2nd quarter valued at about $39,000. Geneos Wealth Management Inc. boosted its stake in shares of Schrodinger by 18.1% during the 2nd quarter. Geneos Wealth Management Inc. now owns 100,329 shares of the company's stock valued at $2,019,000 after purchasing an additional 15,386 shares in the last quarter. Nikko Asset Management Americas Inc. boosted its stake in shares of Schrodinger by 7.2% during the 2nd quarter. Nikko Asset Management Americas Inc. now owns 2,591,492 shares of the company's stock valued at $52,089,000 after purchasing an additional 174,684 shares in the last quarter. Public Sector Pension Investment Board boosted its stake in shares of Schrodinger by 8.3% during the 2nd quarter. Public Sector Pension Investment Board now owns 190,431 shares of the company's stock valued at $3,831,000 after purchasing an additional 14,671 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its position in Schrodinger by 59.5% during the 2nd quarter. Tower Research Capital LLC TRC now owns 14,380 shares of the company's stock valued at $289,000 after acquiring an additional 5,364 shares during the period. Institutional investors own 79.05% of the company's stock.

Schrodinger Stock Performance

Schrodinger stock opened at $20.59 on Friday. The firm's fifty day moving average price is $19.61 and its 200-day moving average price is $21.39. The stock has a market cap of $1.52 billion, a P/E ratio of -8.30 and a beta of 1.74. Schrodinger has a fifty-two week low of $16.60 and a fifty-two week high of $28.47.

Schrodinger (NASDAQ:SDGR - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported ($0.59) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.83) by $0.24. The business had revenue of $54.76 million for the quarter, compared to analyst estimates of $52.03 million. Schrodinger had a negative net margin of 76.22% and a negative return on equity of 45.70%. The company's revenue was up 15.7% on a year-over-year basis. During the same quarter last year, the firm earned ($0.66) EPS. On average, analysts predict that Schrodinger will post -2.37 earnings per share for the current year.

About Schrodinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.